Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction
Paolo Calabresi(Università Cattolica del Sacro Cuore), Veronica Ghiglieri(Agostino Gemelli University Polyclinic)
Cited by 710
Related Papers
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846
Dopamine and cAMP-Regulated Phosphoprotein 32 kDa Controls Both Striatal Long-Term Depression and Long-Term Potentiation, Opposing Forms of Synaptic Plasticity
|Journal of Neuroscience|2000|331
Nicotinic excitation of rat ventral tegmental neurones <i>in vitro</i> studied by intracellular recording
|British Journal of Pharmacology|1989|287
Levodopa in Parkinson’s Disease: Current Status and Future Developments
|Current Neuropharmacology|2017|276